Primary tabs

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

An open label non-randomized phase two trial in metastatic colorectal cancer mCRC with the combination of mFOLFIRI plus Aflibercept as first treatment: MINOAS trial

To evaluate the objective response rates CR and PR of FOLFIRI plus aflibercept as 1st line treatment in patients with mCRC

FieldValue
Modified
2020-03-29
Release Date
2018-06-19
Identifier
958a6a8f-4e6a-476e-9cac-baddaa90e015
License
Public Access Level
Public